Literature DB >> 10451195

The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.

A Anzueto, J A Rizzo, R F Grossman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10451195     DOI： 10.1086/517802

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  10 in total

Review 1.  Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

Authors:  P Zarogoulidis; N Papanas; I Kioumis; E Chatzaki; E Maltezos; K Zarogoulidis
Journal:  Eur J Clin Pharmacol       Date:  2011-11-22       Impact factor: 2.953

2.  [Direct costs to primary care of chronic bronchitis. Analysis of a prospective study].

Authors: 
Journal:  Aten Primaria       Date:  2001-04-15       Impact factor: 1.137

Review 3.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12

4.  Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.

Authors:  Peter Ball
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

5.  A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.

Authors:  Robert Wilson; Antonio Anzueto; Marc Miravitlles; Pierre Arvis; Geneviève Faragó; Daniel Haverstock; Mila Trajanovic; Sanjay Sethi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-06-29

6.  Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy.

Authors:  S Saint; K R Flaherty; P Abrahamse; F J Martinez; A M Fendrick
Journal:  Clin Ther       Date:  2001-03       Impact factor: 3.393

7.  Optimizing economic outcomes in acute exacerbations of chronic bronchitis.

Authors:  Christopher J Destache
Journal:  Pharmacotherapy       Date:  2002-01       Impact factor: 4.705

Review 8.  Role of antimicrobial agents in the management of exacerbations of COPD.

Authors:  Sat Sharma; Nicholas Anthonisen
Journal:  Treat Respir Med       Date:  2005

Review 9.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 10.  Optimizing antibiotic selection in treating COPD exacerbations.

Authors:  Attiya Siddiqi; Sanjay Sethi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.